The forecast of pertussis incidence in the US indicates a gradual decline from 2024 to 2028, with rates decreasing from 4.9 cases per 100,000 in 2024 to 4.4 in 2028. For context, the incidence in 2023 stood at 5.0 cases per 100,000, showing a consistent downward trend year-on-year. The compound annual growth rate (CAGR) over the five-year period reflects an average decrease, suggesting an effective control strategy and possibly improved vaccination coverage.
Future trends to watch include potential shifts in vaccination policy, changes in healthcare access, or the emergence of new pertussis strains, which may impact disease dynamics. Monitoring these factors will be crucial in understanding and responding to pertussis trends effectively.
